GoodRx Holdings, Inc. CFO Transition: Romin Nabiey Appointed as Interim CFO

GoodRx Holdings, Inc. (NASDAQ: GDRX) recently announced a Chief Financial Officer (CFO) transition in a Form 8-K filing submitted to the Securities and Exchange Commission. Karsten Voermann, the current CFO, tendered his resignation for personal reasons effective January 17, 2025.

The Board of Directors swiftly appointed Romin Nabiey, the company’s Chief Accounting Officer, as the Interim CFO starting from the Effective Date. Throughout his career, Nabiey has held various roles in controllership and finance, demonstrating extensive experience in financial domains. He is a licensed CPA and holds dual B.A. degrees in Accounting and Finance.

In connection with Voermann’s departure, the company anticipates entering into a Separation Agreement and Release with him. The agreement outlines terms such as the continuance of stock options and entitlements to the 2024 annual cash incentive, provided Voermann releases all claims against the company.

Following the completion of the CFO transition, Nabiey will simultaneously serve as the principal financial officer, while also maintaining his role as Chief Accounting Officer. The company emphasized that Nabiey has no material interests or family relationships affecting his position within GoodRx.

As per the filing, the Company has entered into a standard indemnification agreement with Nabiey, ensuring standard provisions are in place for his official duties. The agreement was previously filed in Exhibit 10.1 to the Registration Statement on Form S-1/A.

The Board and GoodRx expressed gratitude towards Voermann for his service and contributions. The anticipated transition to Nabiey aims to ensure continuity in financial operations as the company embarks on a search to find a permanent successor. With these changes, GoodRx aims to maintain operational efficiency and financial stability amidst the evolving landscape of the healthcare industry.

For more information on GoodRx and financial updates, interested parties can refer to the company’s official filings with the Securities and Exchange Commission (SEC).

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GoodRx’s 8K filing here.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.